Endo Health Solutions (NASDAQ:ENDP)

	Recent 52-week high
	30% Earnings Per Share (EPS) growth rate
	10% revenue growth year over year
	Strong balance sheet
	15% minimum return on equity (ROE)
	8% minimum pre-tax margins
	Under 50 million shares outstanding
	High insider ownership
	Limited institutional ownership
	P/E at least 1/2 of EPS growth rate

On 2/22/2010 we coded ENDP as a GeoBargain on the radar @ $22.10

On 2/28/2011 we added ENDP to the GeoBargain list @ $36.00

Catalyst: We first starting tracking the ENDP story on 2/22/2010 when the stock was trading at $22.10.  The company had just reported strong fiscal 2009 non-gaap EPS of $2.84 and issued 2010 non-gaap EPS of $3.15 to $3.20.  Continued strong quarterly results as well as the acquisition of AMS (a leading provider of world-class devices and therapies of male and female of pelvic health), lead us to believe the company still had room for growth. 

We are now removing ENDP from the GeoBargain List @ $37.68

Current road block:  Company issued non-gaap EPS guidance of $5.00 to $5.20, below analyst estimates of $5.45; 2013 analyst EPS estimates are calling for less then 10% growth.

Performance:

• Peak performance: Reached a high of  $44.53 on 04/11/2011 for a maiximum potential return of 24%
• Performance based on current price of $37.68: 5%